CorMedix, Inc. (CRMD)
7.19
-0.23
(-3.10%)
USD |
NASDAQ |
Oct 02, 16:00
7.185
0.00 (0.00%)
After-Hours: 20:00
CorMedix Price : 7.19 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 7.45 | 7.45 | 7.165 | 7.19 | 1.125M |
| Oct 01, 2026 | 7.65 | 7.685 | 7.40 | 7.42 | 1.053M |
| Sep 30, 2026 | 7.95 | 7.95 | 7.66 | 7.70 | 948364.0 |
| Sep 29, 2026 | 7.91 | 7.96 | 7.82 | 7.93 | 817427.0 |
| Sep 28, 2026 | 7.772 | 7.90 | 7.772 | 7.89 | 485279.0 |
| Sep 25, 2026 | 7.79 | 7.90 | 7.69 | 7.85 | 606653.0 |
| Sep 24, 2026 | 7.70 | 7.785 | 7.62 | 7.77 | 946581.0 |
| Sep 23, 2026 | 8.025 | 8.185 | 7.625 | 7.69 | 812571.0 |
| Sep 22, 2026 | 7.83 | 7.83 | 7.69 | 7.78 | 788927.0 |
| Sep 21, 2026 | 7.72 | 7.82 | 7.62 | 7.77 | 505842.0 |
| Sep 18, 2026 | 7.65 | 7.79 | 7.62 | 7.72 | 1.806M |
| Sep 17, 2026 | 7.86 | 7.92 | 7.695 | 7.79 | 684745.0 |
| Sep 16, 2026 | 7.78 | 7.87 | 7.72 | 7.82 | 664712.0 |
| Sep 15, 2026 | 7.90 | 7.90 | 7.71 | 7.76 | 718708.0 |
| Sep 14, 2026 | 7.83 | 7.945 | 7.748 | 7.89 | 920273.0 |
| Sep 11, 2026 | 8.04 | 8.06 | 7.82 | 7.825 | 820993.0 |
| Sep 10, 2026 | 8.11 | 8.12 | 7.92 | 7.96 | 857257.0 |
| Sep 09, 2026 | 8.18 | 8.33 | 8.08 | 8.13 | 928241.0 |
| Sep 08, 2026 | 8.28 | 8.37 | 8.11 | 8.18 | 1.101M |
| Sep 04, 2026 | 8.45 | 8.605 | 8.31 | 8.43 | 792913.0 |
| Sep 03, 2026 | 8.69 | 8.745 | 8.43 | 8.47 | 707673.0 |
| Sep 02, 2026 | 8.40 | 8.62 | 8.33 | 8.61 | 1.102M |
| Sep 01, 2026 | 8.25 | 8.49 | 8.18 | 8.38 | 880481.0 |
| Aug 31, 2026 | 8.26 | 8.29 | 8.06 | 8.26 | 980535.0 |
| Aug 28, 2026 | 8.28 | 8.395 | 8.185 | 8.30 | 780215.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Filana Therapeutics, Inc. | 0.9309 |
| Eloxx Pharmaceuticals, Inc. | 15.51 |
| BioStem Technologies, Inc. | 2.73 |
| Wave Life Sciences, Inc. | 3.78 |
| Axsome Therapeutics, Inc. | 179.25 |
Price Related Metrics
| PE Ratio | 3.416 |
| PS Ratio | 1.422 |
| PEG Ratio | 0.0188 |
| Price to Book Value | 1.212 |
| Price to Free Cash Flow | 2.628 |
| Earnings Yield | 29.27% |
| Market Cap | 558.43M |
| PEGY Ratio | 0.0188 |
| Operating PE Ratio | 3.028 |
| Normalized PE Ratio | 3.265 |